||Recombinant human extracellular domain of CD331 cDNA ( 22 – 376 aa, Isoform-1, derived from BC018128 ) fused with T7-His-TEV cleavage site Tag (29aa) at N-terminal was expressed in E. coli.
||1.0 mg/ml in sterile-filtered solution in 20 mM Tris, pH 7.5. Proprietary formulation of NaCl , KCl, EDTA, arginine, DTT, and glycerol.
||MASMTGGQQMGRGHHHHHHGNLYFQGGEFRPSPTLPEQAQPWGAPVEVESFLVHPGDLLQLRCRLRDDVQSINWL RDGVQLAESNRTRITGEEVEVQDSVPADSGLYACVTSSPSGSDTTYFSVNVSDALPSSEDDDDDDDSSSEEKETD NTKPNRMPVAPYWTSPEKMEKKLHAVPAAKTVKFKCPSSGTPNPTLRWLKNGKEFKPDHRIGGYKVRYATWSIIM DSVVPSDKGNYTCIVENEYGSINHTYQLDVVERSPHRPILQAGLPANKTVALGSNVEFMCKVYSDPQPHIQWLKH IEVNGSKIGPDNLPYVQILKTAGVNTTDKEMEVLHLRNVSFEDAGEYTCLAGNSIGLSHHSAWLTVLEALEERPA VMTSPLYLE
||>90% by SDS-PAGE
||1. May be used for in vitro CD331 mediated FGF growth factor pathway regulation study with this protein as either coating matrix protein or soluble factor.2. May be used for CD331 protein-protein interaction assay.3. Potential diagnostic biomarker for cancer and artery diseases.4. As antigen for specific antibody production.
||Keep at -80centigrade for long term storage. Product is stable at 4 centigrade for at least 30 days.